Christopher L. Douglas

1.0k total citations
17 papers, 808 citations indexed

About

Christopher L. Douglas is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Christopher L. Douglas has authored 17 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 6 papers in Cognitive Neuroscience. Recurrent topics in Christopher L. Douglas's work include Neuroscience and Neuropharmacology Research (6 papers), Sleep and Wakefulness Research (5 papers) and Receptor Mechanisms and Signaling (4 papers). Christopher L. Douglas is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Sleep and Wakefulness Research (5 papers) and Receptor Mechanisms and Signaling (4 papers). Christopher L. Douglas collaborates with scholars based in United States and Ireland. Christopher L. Douglas's co-authors include Ralph Lydic, Helen A. Baghdoyan, Chiara Cirelli, Vladyslav V. Vyazovskiy, Giulio Tononi, Michael B. Dash, Beth M. Tyler, Bernadette Cusack, Elliott Richelson and Daniel McCormick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Journal of Neurophysiology.

In The Last Decade

Christopher L. Douglas

16 papers receiving 779 citations

Peers

Christopher L. Douglas
Csaba Ádori Hungary
Gregory C. Sartor United States
Seongsik Yun South Korea
Maysa Sarhan United States
Ron A. Leslie United Kingdom
K. Seto Japan
Csaba Ádori Hungary
Christopher L. Douglas
Citations per year, relative to Christopher L. Douglas Christopher L. Douglas (= 1×) peers Csaba Ádori

Countries citing papers authored by Christopher L. Douglas

Since Specialization
Citations

This map shows the geographic impact of Christopher L. Douglas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Douglas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Douglas more than expected).

Fields of papers citing papers by Christopher L. Douglas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher L. Douglas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Douglas. The network helps show where Christopher L. Douglas may publish in the future.

Co-authorship network of co-authors of Christopher L. Douglas

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher L. Douglas. A scholar is included among the top collaborators of Christopher L. Douglas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher L. Douglas. Christopher L. Douglas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Vegliante, Gloria, Nathan Ryzewski Strogulski, Christopher L. Douglas, et al.. (2025). The NOX2-ROS-NLRP3 inflammasome axis in traumatic brain injury. Journal of Neuroinflammation. 22(1). 242–242.
2.
Orgel, Etan, et al.. (2020). Effect of Body Fat on Population Pharmacokinetics of High‐Dose Methotrexate in Pediatric Patients With Acute Lymphoblastic Leukemia. The Journal of Clinical Pharmacology. 61(6). 755–762. 12 indexed citations
3.
Beck, Thomas W., et al.. (2010). Left thoracotomy surgical approach for chronic instrumentation in dogs and monkeys providing high-quality electrocardiogram signals. Journal of Pharmacological and Toxicological Methods. 62(2). 136–142. 14 indexed citations
4.
Douglas, Christopher L., et al.. (2010). Moxifloxacin in conscious dogs with epicardial ECG leads and semi-automated scoring. Journal of Pharmacological and Toxicological Methods. 62(2). e28–e28. 1 indexed citations
5.
Dash, Michael B., Christopher L. Douglas, Vladyslav V. Vyazovskiy, Chiara Cirelli, & Giulio Tononi. (2009). Long-Term Homeostasis of Extracellular Glutamate in the Rat Cerebral Cortex across Sleep and Waking States. Journal of Neuroscience. 29(3). 620–629. 212 indexed citations
6.
Douglas, Christopher L., Vladyslav V. Vyazovskiy, Teresa Southard, et al.. (2007). Sleep in Kcna2 knockout mice. BMC Biology. 5(1). 42–42. 84 indexed citations
7.
Douglas, Christopher L., et al.. (2004). C57BL/6J and B6.V-LEPOB mice differ in the cholinergic modulation of sleep and breathing. Journal of Applied Physiology. 98(3). 918–929. 23 indexed citations
8.
Douglas, Christopher L., George J. DeMarco, Helen A. Baghdoyan, & Ralph Lydic. (2004). Pontine and basal forebrain cholinergic interaction: implications for sleep and breathing. Respiratory Physiology & Neurobiology. 143(2-3). 251–262. 21 indexed citations
9.
Lydic, Ralph, Christopher L. Douglas, & Helen A. Baghdoyan. (2002). Microinjection of Neostigmine into the Pontine Reticular Formation of C57BL/6J Mouse Enhances Rapid Eye Movement Sleep and Depresses Breathing. SLEEP. 25(8). 835–841. 43 indexed citations
10.
Douglas, Christopher L., Helen A. Baghdoyan, & Ralph Lydic. (2002). Postsynaptic Muscarinic M1 Receptors Activate Prefrontal Cortical EEG of C57BL/6J Mouse. Journal of Neurophysiology. 88(6). 3003–3009. 26 indexed citations
11.
Douglas, Christopher L., Helen A. Baghdoyan, & Ralph Lydic. (2002). Prefrontal Cortex Acetylcholine Release, EEG Slow Waves, and Spindles Are Modulated by M2 Autoreceptors in C57BL/6J Mouse. Journal of Neurophysiology. 87(6). 2817–2822. 28 indexed citations
12.
Douglas, Christopher L., Helen A. Baghdoyan, & Ralph Lydic. (2001). M2 Muscarinic Autoreceptors Modulate Acetylcholine Release in Prefrontal Cortex of C57BL/6J Mouse. Journal of Pharmacology and Experimental Therapeutics. 299(3). 960–966. 58 indexed citations
13.
Tyler, Beth M., Karen Jansen, Daniel McCormick, et al.. (1999). Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood–brain barrier and specifically reduce gene expression. Proceedings of the National Academy of Sciences. 96(12). 7053–7058. 98 indexed citations
14.
Tyler, Beth M., Christopher L. Douglas, Abdul H. Fauq, et al.. (1999). In vitro binding and CNS effects of novel neurotensin agonists that cross the blood–brain barrier. Neuropharmacology. 38(7). 1027–1034. 65 indexed citations
16.
Tyler, Beth M., Daniel McCormick, Christopher L. Douglas, et al.. (1998). Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo. FEBS Letters. 421(3). 280–284. 72 indexed citations
17.
Douglas, Christopher L., Hartmut Derendorf, & John P. Anhalt. (1991). COMPARATIVE PHARMACOKINETICS OF TRIMETHOPRIM-SULFAMETHOXAZOLE ADMINISTERED INTRAVENOUSLY AND ORALLY TO CAPTIVE ELEPHANTS. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026